Prognostic classifier for predicting biochemical recurrence in localized prostate cancer patients after radical prostatectomy.

CONCLUSION: Combination of gene expression patterns and clinicopathological variables in a robust, easy-to-use, and reliable classifier may contribute to improve PCa risk stratification.
PMID: 33189527 [PubMed - as supplied by publisher]

Source: Urologic Oncology - November 11, 2020 Category: Urology & Nephrology Authors: Carrion A, Ingelmo-Torres M, Lozano JJ, Montalbo R, D'Anna M, Mercader C, Velez E, Ribal MJ, Alcaraz A, Mengual L Tags: Urol Oncol Source Type: research